Patient Therapeutic Education (PTE) in the rehabilitation process of stroke patients: improving self management and fostering transition from hospital to community

Patient Therapeutic Education (PTE) in the rehabilitation process of stroke patients: improving self management and fostering transition from hospital to community. A non-randomized clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN75290225

Enrollment

240

Registered

2015-08-25

Start date

2014-10-01

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

First stroke patients with mild/moderate to severe disability Circulatory System Stroke, not specified as haemorrhage or infarction

Interventions

The project will be run in two phases: Phase 1: 1. Design and standardization of the therapeutic education intervention

the intervention will be based on the Chronic Disease Self Management Program which will be adapted and tailored to the specific needs of stroke patients in the early rehabilitation phase. 2. Training

the Units are selected on the basis of similarities of the stroke rehabilitation pathway adopted. Patients admitted to Rehabilitation Unit 1 (Bologna) will receive 'usual care'

patients admitted to Rehabilitation Unit 2 Reggio E.-AO and Rehabilitation Unit 3 Modena-AUSL will receive the experimental intervention. 2. A feasibility assessment study will be conducted with spec

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who suffered a first stroke at the admission to hospital rehabilitation phase (age >18) 2. Having a caregiver as reference person 3. Mild/moderate to severe disability (modified Barthel Index <70/100) 4. Communication disability from absent to mild (Communication Disability Scale <3) 5. Informed consent form signed both by patient and caregiver

Exclusion criteria

Exclusion criteria: 1. Previous stroke episodes 2. Severe cognitive impairment (MMSE or=3) 3. Life threatening diseases 4. No consent to participation

Design outcomes

Primary

Measure	Time frame
Self-efficacy, measured using the Stroke Self-efficacy Questionnaire at the end of treatment and at follow-up	—

Secondary

Measure	Time frame
1. Health-related quality of life, measuring using SF-12 2. The ability to perform daily living activities, measured using the Modified Barthel Index 3. The presence and severity of depression, measured using the Geriatric Depression Scale 4. The caregiver’s burden, measured using the Caregiver Strain Index 5. Patient/caregiver satisfaction, measured using a self-report visual analog scale 6. Mobility, measured using the Short Physical Performance Battery Measured at the end of treatment and at follow-up	—

Measure

Time frame

1. Health-related quality of life, measuring using SF-12 2. The ability to perform daily living activities, measured using the Modified Barthel Index 3. The presence and severity of depression, measured using the Geriatric Depression Scale 4. The caregiver’s burden, measured using the Caregiver Strain Index 5. Patient/caregiver satisfaction, measured using a self-report visual analog scale 6. Mobility, measured using the Short Physical Performance Battery Measured at the end of treatment and at follow-up

—

Countries

Italy

Contacts

Public ContactMariangela Taricco

mariangela.taricco@aosp.bo.it+39 (0)51 2142286

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 5, 2026